Learn more about the Registry
ZEPOSIA UC Pregnancy Registry toll-free number
1-877-331-1166
The ZEPOSIA UC Pregnancy Registry
Are you pregnant and diagnosed with ulcerative colitis? Have you taken ZEPOSIA® (ozanimod) or other ulcerative colitis medications during your pregnancy?
Ulcerative colitis can be a debilitating condition. Help future pregnant women, doctors, and researchers understand the safety of medications that can provide some relief.
Are you a healthcare provider who treats pregnant women with ulcerative colitis?
Help us learn more about the safety of using ZEPOSIA® (ozanimod) and other ulcerative colitis medications during pregnancy.
About ZEPOSIA UC Pregnancy Registry
The goal of the ZEPOSIA UC Pregnancy Registry is to help doctors, patients, and researchers better understand the safety of ZEPOSIA® (ozanimod) and other ulcerative colitis medications used during pregnancy. Pregnant women in the United States or Canada with ulcerative colitis may be eligible to participate. The study collects health information from enrolled pregnant women and their healthcare providers related to their pregnancies and developing babies up to 1 year of age.
Would you like to participate?
What is ZEPOSIA® (ozanimod)?
ZEPOSIA® (ozanimod) is a prescription medicine made by Celgene Corporation, a Bristol-Myers Squibb Company, that is used for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).